BBS5 and Bardet-Biedl syndrome: The patient had mutations in the BBS10 gene, and therefore direct extrapolations from the Bbs5–/– rodent model cannot be made; however, as studies have not been performed to date, this is the only evidence to suggest retained GLP-1RA sensitivity in patients with BBS.